Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

PROTEOMICS – Clinical Applications, 2024
Methods and clinical biomarker discovery for targeted proteomics using Olink technology

Wang H., Zhao T., Zeng J. et al.

Wider Proteomics StudiesReview/editorial

Immunology & Cell Biology, 2024
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation

Alexandersson A., Venäläinen M., Heikkilä N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Frontiers in Immunology, 2024
Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

Ni W., Ren L., Liao L. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

BMJ Oncology, 2024
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours

Naing A., Papadopoulos K., Pishvaian M. et al.

Olink Target 96OncologyPathophysiologyPlasma

Ticks and Tick-borne Diseases, 2024
Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis

Fredriksson T., Brudin L., Henningsson A. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Biomolecules, 2024
GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing

Kasher M., Freidin M., Williams F. et al.

Olink Target 96Immunological & Inflammatory DiseasesAgingPathophysiologyBlood

Journal of the European Academy of Dermatology and Venereology, 2024
Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis

Soenen R., Schots L., Wang Z. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Clinical Immunology, 2024
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation

Reiter A., Verweyen E., Queste E. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum

JCI Insight, 2024
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans

Hellgren F., Rosdahl A., Arcoverde Cerveira R. et al.

Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant

Heart & Lung, 2024
Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function

Ruan W., Zhou X., Liu H. et al.

Olink Target 96CVDPathophysiologyPlasma

Heliyon, 2024
Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment

Leierer J., Salib M., Evgeniou M. et al.

Olink Target 96CVDNephrologyPatient StratificationPlasma

Brain, Behavior, and Immunity, 2024
Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study

Beydoun M., Beydoun H., Hu Y. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Molecular & Cellular Proteomics, 2024
Pericyte-Specific Secretome Profiling in Hypoxia Using TurboID in a Multicellular in Vitro Spheroid Model

Enström A., Carlsson R., Buizza C. et al.

Olink Target 96NeurologyPathophysiologyTechnical EvaluationCell Culture Supernatant

Medicine, 2024
Exploring the casual association between gut microbiome, circulating inflammatory cytokines and chronic pancreatitis: A Mendelian randomization analysis

Yang X., Xu H., Liang X. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Cell Reports Medicine, 2024
Metabolic liability for weight gain in early adulthood

Murthy V., Mosley J., Perry A. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
Examination of the Complex Molecular Landscape in Obesity and Type 2 Diabetes

Vadadokhau U., Varga I., Káplár M. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPatient StratificationPlasma

Journal of Pediatric Gastroenterology and Nutrition, 2024
Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease

Winter D., de Bruyne P., van der Woude J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal of Allergy and Clinical Immunology, 2024
IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease

Chen C., Buchheit K., Lee P. et al.

Olink Target 48Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyNasal Fluid

Immuno-Oncology and Technology, 2024
Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy—a retrospective and biomarker study

Costa Svedman F., Liapi M., Månsson-Broberg A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2024
Early Mortality in Clinical Trials of Acute Respiratory Distress Syndrome

Giannakoulis V., Schenck E., Papoutsi E. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

3195 publications